Versatile Amplification Method for Single-Molecule Detection in Liquid Biopsy – VerSiLiB

VerSiLiB project aims to develop a proof-of-concept of a novel in-vitro diagnostic system that combines the analysis of DNA and protein biomarkers into one proteogenomic test. Project is the first step in our journey to enable fast and easy-to-use proteogenomic tests that will be widely applicable in the diagnosis of several significant diseases including viral outbreaks, cancers, neuro-degenerative immune and cardiovascular diseases. In the end of the project, the developed technology will be validated for real-life cancer management in a clinical setting.

VerSiLiB (grant agreement No 101046217) is a 4-year EIC Pathfinder Open project that has received EUR 3 million funding from the European Union’s European Innovation Council (EIC) under Horizon Europe program.